These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 7585605

  • 21. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.
    Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI.
    Oncogene; 1997 Nov 27; 15(22):2727-33. PubMed ID: 9400999
    [Abstract] [Full Text] [Related]

  • 22. Duplication of an approximately 1.5 Mb DNA segment at chromosome 5q22 indicates the locus of a new tumour gene in nonpapillary renal cell carcinomas.
    Kenck C, Bugert P, Wilhelm M, Kovacs G.
    Oncogene; 1997 Mar 06; 14(9):1093-8. PubMed ID: 9070658
    [Abstract] [Full Text] [Related]

  • 23. Allelic deletions in renal tumors: histopathological correlations.
    Presti JC, Reuter VE, Cordon-Cardo C, Mazumdar M, Fair WR, Jhanwar SC.
    Cancer Res; 1993 Dec 01; 53(23):5780-3. PubMed ID: 8242636
    [Abstract] [Full Text] [Related]

  • 24. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L.
    Clin Cancer Res; 2005 Oct 15; 11(20):7226-33. PubMed ID: 16243792
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
    Ogawa O, Habuchi T, Kakehi Y, Koshiba M, Sugiyama T, Yoshida O.
    Cancer Res; 1992 Apr 01; 52(7):1881-5. PubMed ID: 1348014
    [Abstract] [Full Text] [Related]

  • 28. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma.
    Alimov A, Kost-Alimova M, Liu J, Li C, Bergerheim U, Imreh S, Klein G, Zabarovsky ER.
    Oncogene; 2000 Mar 09; 19(11):1392-9. PubMed ID: 10723130
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. Correlation with tumor karyotypes.
    Hughson MD, Meloni A, Dougherty S, Silva FG, Sandberg AA.
    Cancer Genet Cytogenet; 1996 Apr 09; 87(2):133-9. PubMed ID: 8625259
    [Abstract] [Full Text] [Related]

  • 34. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P, Marchini S, Rader JS, Martinez A, Macartney D, Broggini M, Morelli C, Barbanti-Brodano G, Maher ER, Latif F.
    Cancer Res; 1999 Sep 15; 59(18):4662-7. PubMed ID: 10493522
    [Abstract] [Full Text] [Related]

  • 35. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JD.
    Cancer Res; 2000 Apr 01; 60(7):1949-60. PubMed ID: 10766185
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.